In this interactive session, clinicians, neuroscientists, engineers, data scientists, and interested members of our community with Parkinsons will learn about new insights and tools that our Blue Sky researchers are using as possible therapeutics (at the cellular level) for Parkinson's disease.
Featured Presenters:
"Force-dependent interaction and mechano-regulation of microglial and neuronal cell receptors Mac-1 and Lag3 by α-synuclein in Parkinson’s disease".
Cheng Zhu, Ph.D., Biomedical Engineering,Georgia Tech and Emory University
"Altruistic MSC-Based Mitochondrial Therapy for Parkinson’s Disease".
Melissa Kemp, Ph.D., Biomedical Engineering, Georgia Tech and Emory University
Levi Wood, Ph.D., Mechanical Engineering, Georgia Tech